(06 Nov 2020) Artemisinin- in combination with Piperaquine significantly reduced the time to reach undetectable SARS-CoV-2
Safety and efficacy of Artemisinin-Piperaquine for treatment of COVID-19: an open-label, non-randomized, and controlled trial https://doi.org/10.1016/j.ijantimicag.2020.106216 In an open label clinical trial (ChiCTR2000033049), Forty-one patients with confirmed COVID-19 were enrolled in the study and divided into two groups: artemisinin-piperaquine (AP)… Continue reading "(06 Nov 2020) Artemisinin- in combination with Piperaquine significantly reduced the time to reach undetectable SARS-CoV-2"